var title_f4_6_4192="Stretching exercises PI";
var content_f4_6_4192=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stretching exercises",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 276px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Back stretch.",
"    <br/>",
"    (B) Shoulder shrug.",
"    <br/>",
"    (C) Neck stretch.",
"    <br/>",
"    (D) Arm circles.",
"    <br/>",
"    (E) Standing groin stretch.",
"    <br/>",
"    (F) Calf stretch.",
"    <br/>",
"    (G) Modified sit-up.",
"    <br/>",
"    (H) Hamstring stretch.",
"    <br/>",
"    (I) Sitting groin stretch.",
"    <br/>",
"    (J) Side stretch.",
"    <br/>",
"    (K) Quadricep stretch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4192=[""].join("\n");
var outline_f4_6_4192=null;
var title_f4_6_4193="Benzylthiouracil: International drug information";
var content_f4_6_4193=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Benzylthiouracil: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Basdene (FR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1977923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antithyroid Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1977926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hyperthyroidism",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1977922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: Initial: 150-200 mg/day in 3-4 divided doses; may decrease to 100 mg/day after several weeks",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1977925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 25 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10536 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-9DBBEBA25B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4193=[""].join("\n");
var outline_f4_6_4193=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304142\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977923\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977926\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977922\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821220\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977925\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10536\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10536|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_6_4194="Pediculosis pubis louse";
var content_f4_6_4194=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pthirus pubis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pubic louse.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Koneman's Color Atlas and Textbook of Diagnostic Microbiology, Fifth Edition, Lippincott-Raven, Philadelphia 1997. Copyright &copy; 1997 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4194=[""].join("\n");
var outline_f4_6_4194=null;
var title_f4_6_4195="Removal of spherical ear foreign body";
var content_f4_6_4195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Removal of spherical external auditory canal foreign body using a Schuknecht foreign body remover",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 344px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     The Schuknecht foreign body remover is attached to the mobile round foreign body and suction is applied for extraction.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from illustration by&nbsp;Glenn Isaacson MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4195=[""].join("\n");
var outline_f4_6_4195=null;
var title_f4_6_4196="Tigecycline: Patient drug information";
var content_f4_6_4196=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tigecycline: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     see \"Tigecycline: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/3/31796?source=see_link\">",
"     see \"Tigecycline: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F786537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tygacil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9749224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Tygacil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703033",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tigecycline or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701388",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a tetracycline allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11448 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-87592D432B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4196=[""].join("\n");
var outline_f4_6_4196=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F786537\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9749224\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022085\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022087\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022086\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022091\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022092\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022094\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022089\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022090\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022096\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=related_link\">",
"      Tigecycline: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/3/31796?source=related_link\">",
"      Tigecycline: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_6_4197="Midazolam: Patient drug information";
var content_f4_6_4197=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Midazolam: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     see \"Midazolam: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/46/746?source=see_link\">",
"     see \"Midazolam: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F196443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Midazolam&reg;;",
"     </li>",
"     <li>",
"      Midazolam Injection",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10013765\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause trouble breathing. Call your doctor right away if you have slow breathing, shallow breathing, or trouble breathing. Older adults may have more side effects and will be started at a lower dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm you before care.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702525",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to midazolam or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for more than 10 days, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697935",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in balance.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If anything causes you worry, if any of the unwanted side effects happen, or if your signs do not get better after taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given 30 to 45 minutes before care.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is given on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10858 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-4C9EBFD82E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4197=[""].join("\n");
var outline_f4_6_4197=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196443\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013765\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013767\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013766\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013771\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013772\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013774\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013769\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013770\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013775\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013776\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=related_link\">",
"      Midazolam: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/46/746?source=related_link\">",
"      Midazolam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_6_4198="Pancreatic imaging in SDS";
var content_f4_6_4198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic imaging in Shwachman-Diamond syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 463px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Normal pancreas in a 7-year-old girl. A transverse sonogram of the upper abdomen shows the normal pancreas (arrows), which is isoechoic to liver. B)&nbsp;Pancreas in a 3-year old boy with Shwachman-Diamond syndrome. Transverse sonogram of the upper abdomen reveals an enlarged, diffusely echogenic pancreas (arrows) due to fatty infiltration. Note normal adjacent liver (L). C) Normal pancreas in a 16-year-old girl. A transverse computed tomography image demonstrates a normal pancreas. The density of the pancreas (arrows) is similar to liver. D)&nbsp;Pancreas in a 5-year-old boy with Shwachman-Diamond syndrome. Transverse contrast-enhanced computed tomography image shows diffuse fatty infiltration of the pancreas (arrowheads). Similar computed tomography findings can be seen with cystic fibrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Shimamura, A. Schwachman-Diamond Syndrome. Seminars in Hematology 2006; 43:178. Copyright &copy;2006 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4198=[""].join("\n");
var outline_f4_6_4198=null;
var title_f4_6_4199="Immature teratoma High";
var content_f4_6_4199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mediastinal immature teratoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power photomicrograph of a mediastinal immature teratoma shows immature neuroectodermal elements with rosette formation, lined by crowded basophilic cells with hyperchromatic nuclei. (Hematoxylin and eosin, magnification 100x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4199=[""].join("\n");
var outline_f4_6_4199=null;
var title_f4_6_4200="Penicillamine: Drug information";
var content_f4_6_4200=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Penicillamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?33/20/34117?source=see_link\">",
"    see \"Penicillamine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/26/6566?source=see_link\">",
"    see \"Penicillamine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F207480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cuprimine&reg;;",
"     </li>",
"     <li>",
"      Depen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F207481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cuprimine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F207525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Chelating Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F207484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose reduction to 250 mg/day may be considered prior to surgical procedures. May resume normal recommended dosing post-operatively once wound healing is complete.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cystinuria:",
"     </b>",
"     Oral: 1-4 g/day in 4 divided doses; usual dose: 2 g/day; initiation of therapy at 250 mg/day with gradual upward titration may reduce the risk of unwanted effects.",
"     <b>",
"      Note:",
"     </b>",
"     Adjust dose to limit cystine excretion to 100-200 mg/day (&lt;100 mg/day with history of stone formation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lead poisoning:",
"     </b>",
"     Oral:",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     900-1500 mg/day in 3 divided doses for 1-2 weeks, then 750 mg/day in divided doses until blood lead concentrations &lt;60 mcg/dL or urinary lead excretion &lt;500 mcg/L for 2 consecutive months.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rheumatoid arthritis:",
"     </b>",
"     Oral: Initial: 125-250 mg/day, may increase dose by 125-250 mg/day at 1- to 3-month intervals up to 1-1.5 g/day; discontinue in patients failing to improve after 3-4 months at these doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Wilson's disease:",
"     </b>",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Dose that results in an initial 24-hour urinary copper excretion &gt;2 mg/day should be continued for ~3 months; maintenance dose defined by amount resulting in &lt;10 mcg serum free copper/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Manufacturer labeling recommendations:",
"     </i>",
"     750-1500 mg/day in divided doses; maximum dose: 2000 mg/day.",
"     <b>",
"      Note:",
"     </b>",
"     Limit daily dose to 750 mg/day (U.S. labeling) or 1000 mg/day (Canadian labeling) in pregnant women; if planned caesarian, limit dose to 250 mg/day during the last 6 weeks of pregnancy and postoperatively until wound healing is complete.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Alternate recommendations (unlabeled dosing):",
"     </i>",
"     To increase tolerability, therapy may be initiated at 250-500 mg/day then titrated upward in 250 mg increments every 4-7 days; usual maintenance dose: 750-1000 mg/day  in 2 divided doses; maximum: 1000-1500 mg/day in 2-4 divided doses. (American Association for the Study of Liver Diseases [AASLD] guidelines) (Roberts, 2008).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F207504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/26/6566?source=see_link\">",
"      see \"Penicillamine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose reduction to 250 mg/day may be considered prior to surgical procedures. May resume normal recommended dosing postoperatively once wound healing is complete.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cystinuria:",
"     </b>",
"     Oral: 30 mg/kg/day in 4 divided doses;",
"     <b>",
"      Note:",
"     </b>",
"     Adjust dose to limit cystine excretion to 100-200 mg/day (&lt;100 mg/day with history of stone formation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lead poisoning:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     30-40 mg/kg/day or 600-750 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day in 1-2 divided doses (maximum dose: 750 mg/day); treat until blood lead concentrations &lt;40 mcg/dL for 2 consecutive months and at least 1 of the following: Decrease in erythrocyte protoporphyrin level to &lt;3-5 times the average normal level or the excretion of coproporphyrin or delta-aminolevulinic acid decreases to the upper limit of normal.",
"     <b>",
"      Note:",
"     </b>",
"     Manufacturer labeling recommends initiating therapy only in children who meet the following criteria: Asymptomatic, blood lead concentrations of 50-80 mcg/dL, erythrocyte protoporphyrin level &gt;400-500 mcg/dL erythrocytes, excessive excretion of delta-aminolevulinic acid and/or coproporphyrin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Alternate recommendations (unlabeled dosing):",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     The American Academy of Pediatrics (AAP) considers penicillamine a third-line agent for the management of lead poisoning (AAP, 2005; Chandran, 2010): 10-15 mg/kg/day for 4-12 weeks (Chandran, 2010).",
"     <b>",
"      Note:",
"     </b>",
"     The CDC recommends chelation treatment when blood lead concentrations are &gt;45 mcg/dL (CDC, 2002). Children with blood lead concentrations &gt;70 mcg/dL or symptomatic lead poisoning should be treated with parenteral agents (AAP, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Wilson's disease (unlabeled dosing):",
"     </b>",
"     Oral: 20 mg/kg/day in 2-3 divided doses, round off to the nearest 250 mg dose (American Association for the Study of Liver Diseases [AASLD] guidelines) (Roberts, 2008).",
"     <b>",
"      Note:",
"     </b>",
"     Dose that results in an initial 24-hour urinary copper excretion &gt;2 mg/day should be continued for ~3 months; maintenance dose defined by amount resulting in &lt;10 mcg serum free copper/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rheumatoid arthritis (unlabeled use):",
"     </b>",
"     Oral: Initial: 3 mg/kg/day (&le;250 mg/day) for 3 months, then 6 mg/kg/day (&le;500 mg/day) in divided doses twice daily for 3 months to a maximum of 10 mg/kg/day in 3-4 divided doses; maximum dose: 750 mg/day (Rosenberg, 1989)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F207485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapy should be initiated at low end of dosing range and titrated upward cautiously. Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F207486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;display:inline\">",
"     <i>",
"      Manufacturer labeling recommendations:",
"     </i>",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; however, the manufacturer labeling does suggest a cautious approach to dosing as this drug undergoes mainly renal elimination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Alternate recommendations:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute: Avoid use (Aronoff, 2007",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Hemodialysis: Dialyzable; Administer 33% of usual dose (Aronoff, 2007); a dosing decrease from 250 mg/day to 250 mg 3 times/week after dialysis has been suggested in the treatment of rheumatoid arthritis (Swarup, 2004).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13804101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; however, only a small fraction is metabolized hepatically.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F207453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cuprimine&reg;: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Depen&reg;: 250 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F207438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F207457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Doses &le; 500 mg may be administered as single dose; doses &gt;500 mg should be administered in divided doses. For patients who cannot swallow, contents of capsules may be administered in 15-30 mL of chilled pur&eacute;ed fruit or fruit juice within 5 minutes of administration. Administer on an empty stomach (1 hour before or 2 hours after meals) and at least 1 hour apart from other drugs, milk, antacids, and zinc or iron-containing products. Canadian labeling recommends administering at least 2 hours before meals in patients with lead poisoning.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cystinuria: If administering 4 equal doses is not feasible, administer the larger dose at bedtime.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F207456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of Wilson's disease, cystinuria; adjunctive treatment of severe, active rheumatoid arthritis",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional use (not in U.S. labeling): Treatment of chronic lead poisoning",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F207532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Penicillamine may be confused with penicillin",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Depen [U.S.] may be confused with Depin brand name for nifedipine [India]; Depon brand name for acetaminophen [Greece]; Dipen brand name for diltiazem [Greece]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Pemine [Italy] may be confused with Pamine brand name for methscopolamine [U.S., Canada]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F207523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined and may vary by indication.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Vasculitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, agitation, fever, Guillain-Barr&eacute; syndrome, hyperpyrexia, psychiatric disturbances, worsening neurologic symptoms",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, cheilosis, dermatomyositis, drug eruptions, exfoliative dermatitis, lichen planus, pemphigus, pruritus, rash (early and late: 5%), skin friability increased, toxic epidermal necrolysis, urticaria, wrinkling (excessive), yellow nail syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypoglycemia, thyroiditis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (17%), taste alteration (12%), anorexia, epigastric pain, gingivostomatitis, glossitis, nausea, oral ulcerations, pancreatitis, peptic ulcer reactivation, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Thrombocytopenia (4%), leukopenia (2%), agranulocytosis, aplastic anemia, eosinophilia, hemolytic anemia, leukocytosis,  monocytosis, red cell aplasia, sideroblastic anemia, thrombotic thrombocytopenia purpura, thrombocytosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, hepatic failure, intrahepatic cholestasis, toxic hepatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Thrombophlebitis, white papules at venipuncture and surgical sites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, dystonia, myasthenia gravis, muscle weakness, neuropathies, polyarthralgia (migratory, often with objective synovitis), polymyositis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Diplopia, extraocular muscle weakness, optic neuritis, ptosis, visual disturbances",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Proteinuria (6%), Goodpasture's syndrome, hematuria, nephrotic syndrome, renal failure, renal vasculitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma, interstitial pneumonitis, pulmonary fibrosis, obliterative bronchiolitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic alveolitis, anetoderma, elastosis perforans serpiginosa, lupus-like syndrome, lactic dehydrogenase increased, lymphadenopathy, mammary hyperplasia, positive ANA test",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F207461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal insufficiency (in patients with rheumatoid arthritis); patients with previous penicillamine-related aplastic anemia or agranulocytosis; breast-feeding; pregnancy (in patients with rheumatoid arthritis)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Hypersensitivity to penicillamine or any component of the formulation; use in patients with chronic lead poisoning who have radiographic evidence of lead-containing substances in the GI tract; pregnancy (in patients with chronic lead poisoning); concomitant use with gold therapy, antimalarial or cytotoxic drugs, oxyphenbutazone or phenylbutazone",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F207442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Allergic reactions: Approximately 33% of patients will experience an allergic reaction. Rash may occur early (more commonly) or late in therapy; early-onset rash typically resolves within days of discontinuation of therapy and does not recur upon rechallenge with reduced dose; discontinue therapy for late-onset rash (eg, after &gt;6 months) and do not rechallenge; rash typically recurs with rechallenge.  Discontinue therapy for skin reactions accompanied by lymphadenopathy, fever, arthralgia, or other allergic reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bronchiolitis obliterans: Has been reported rarely with use; instruct patients to report pulmonary symptoms (eg, unexplained wheezing or cough, exertional dyspnea) and consider pulmonary function testing in such patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dermatologic: Penicillamine increases the amount of soluble collagen; may increase skin friability, particularly at sites subject to pressure or trauma (eg, knees, elbows shoulders). Purpuric areas with localized bleeding (if skin is broken) or vesicles with dark blood may be observed. Effects are considered localized and do not necessitate discontinuation of therapy; may not recur with dose reduction.  Macular cutaneous eruptions are sometimes observed in conjunction with drug fever, usually 2 -3 weeks after therapy initiation. Dose reduction may be considered prior to surgical procedures. May resume normal recommended dosing postoperatively once wound healing is complete.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug fever: Drug fever may be observed, usually 2-3 weeks after therapy initiation. Discontinue use in patients with rheumatoid arthritis, Wilson&rsquo;s disease, or cystinuria who develop a marked febrile response. Consider alternative therapy for patients with rheumatoid arthritis due to high incidence of fever reoccurrence with penicillamine rechallenge. May resume therapy at a reduced dose in Wilson&rsquo;s disease or cystinuria upon resolution of fever; dose should then be gradually titrated to effective dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal: Taste alteration may occur (rare in Wilson&rsquo;s disease); usually self-limited with continued therapy, however may last &ge;2 months and result in total loss of taste. Oral ulceration (eg, stomatitis) may occur; typically recurs on rechallenge but often resolves with dose reduction. Other dose-related lesions (eg, glossitis, gingivostomatitis) have been observed with use and may require therapy discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Goodpasture's syndrome: Penicillamine has been associated with fatalities due to Goodpasture's syndrome. Discontinue therapy immediately in patients with abnormal urinary findings in association with hemoptysis and pulmonary infiltrates on chest x-ray.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic toxicities: Penicillamine has been associated with fatalities due to agranulocytosis, aplastic anemia, and thrombocytopenia. Discontinue therapy for WBC &lt;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     . Withhold therapy at least temporarily for platelet counts &lt;100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     or a progressive fall in WBC or platelets in 3 successive determinations, even though values may remain within the normal range. Monitor for signs/symptoms of leukopenia and thrombocytopenia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity: Monitor liver function tests periodically due to rare reports of intrahepatic cholestasis or toxic hepatitis. More frequent monitoring is required during the first year of therapy in patients with Wilson&rsquo;s disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lupus erythematosus-like syndrome: May be observed in some patients; positive antinuclear antibody (ANA) test does not necessitate therapy discontinuation but should alert clinicians of possible future development of lupus erythematosus-like syndrome.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pemphigus: May occur early or late in therapy; discontinue use with suspicion of pemphigus. May treat with high-dose corticosteroids alone, or in conjunction with an immunosuppressant; treatment duration can range from weeks to &gt;1 year.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Penicillin cross-sensitivity: Patients with a penicillin allergy may theoretically have cross-sensitivity to penicillamine; however, the possibility has been eliminated now that penicillamine is produced synthetically and no longer contains trace amounts of penicillin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Proteinuria/hematuria: Proteinuria or hematuria may develop; monitor for membranous glomerulopathy which can lead to nephrotic syndrome. In rheumatoid arthritis patients, discontinue if gross hematuria or persistent microscopic hematuria develop and discontinue therapy or reduce dose for proteinuria that is either &gt;1 g/day or progressively increasing.  Dose reduction may lead to resolution of proteinuria.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Penicillamine has been associated with myasthenic syndrome, and in some cases, progression to  myasthenia gravis. Resolution of symptoms has been observed in most cases following discontinuation of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Toxicity symptoms:",
"     <b>",
"      [U.S. Boxed Warning]: Patients should be warned to report promptly any symptoms suggesting toxicity (fever, sore throat, chills, bruising, or bleeding);",
"     </b>",
"     toxicity may be dose related.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cystinuria: Continue treatment on a daily basis; interruptions of even a few days have been followed by hypersensitivity with reinstitution of therapy.  Patients should receive pyridoxine supplementation (25 mg/day).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lead poisoning: Investigate, identify, and remove sources of lead exposure and confirm lead-containing substances are absent from the GI tract prior to initiating therapy. Do not permit patients to re-enter the contaminated environment until lead abatement has been completed.  Penicillamine is considered to be a third-line agent for the treatment of lead poisoning in children due to the overall toxicity associated with its use (AAP, 2005; Chandran, 2010); penicillamine should only be used when unacceptable reactions have occurred with edetate CALCIUM disodium and succimer. Primary care providers should consult experts in the chemotherapy of lead toxicity before using chelation drug therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Rheumatoid arthritis: Patients with rheumatoid arthritis and impaired nutrition should receive pyridoxine supplementation (25 mg/day).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Wilson's disease: Continue treatment on a daily basis; interruptions of even a few days have been followed by hypersensitivity with reinstitution of therapy.  Worsening of neurologic symptoms may occur during initiation of therapy however discontinuation of therapy is not recommended; may consider concomitant use of short term dimercaprol in patients whose symptoms continue to worsen 1 month following therapy initiation. Patients should receive pyridoxine supplementation (25-50 mg/day; Roberts, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematopoietic-depressant drugs: Use with caution in patients on other hematopoietic-depressant drugs (eg, gold, immunosuppressants, antimalarials, phenylbutazone; Canadian labeling contraindicates concomitant use with these agents); hematologic and renal adverse reactions are similar.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more susceptible to skin rash and/or taste alterations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced physician:",
"     <b>",
"      [U.S. Boxed Warning]: Should be administered under the close supervision of a physician familiar with the toxicity and dosage considerations.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F207447\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the serum concentration of PenicillAMINE.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Digoxin: PenicillAMINE may decrease the serum concentration of Digoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the absorption of PenicillAMINE. Only oral iron salts are a concern.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May increase the serum concentration of PenicillAMINE. Management: Consider separating doses of the agents by 2 or more hours to minimize the effects of this interaction; however, the success of this action is unproven.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F207475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Management: Avoid or limit ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Penicillamine serum levels may be decreased if taken with food. Management: Administer on an empty stomach 1 hour before or 2 hours after meals and at least 1 hour apart from other drugs, milk, antacids, and zinc- or iron-containing products. Certain disease states require further diet adjustment. Limit intake of vitamin A.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F207449\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F207464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Birth defects, including congenital cutix laxa and associated defects, have been reported in infants following penicillamine exposure during pregnancy. Use for the treatment of rheumatoid arthritis during pregnancy is contraindicated. Use for the treatment of cystinuria only if the possible benefits to the mother outweigh the potential risks to the fetus. Continued treatment of Wilson's disease during pregnancy protects the mother against relapse. Discontinuation has detrimental maternal and fetal effects. Daily dosage should be limited to 750 mg. For planned cesarean section, reduce dose to 250 mg/day for the last 6 weeks of pregnancy, and continue at this dosage until wound healing is complete.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F207490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F207465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken at least 1 hour before or 2 hours after meals on an empty stomach (Note: Canadian labeling recommends administration at least 2 hours before meals in patients with lead poisoning).  Pyridoxine supplementation is recommended. Patients with Wilson's disease should receive 25-50 mg/day of pyridoxine (Roberts, 2008); a multivitamin (without copper) may also be considered. Patients with cystinuria or patients with rheumatoid arthritis and impaired nutritional intake should receive 25 mg/day of pyridoxine. For Wilson's disease, decrease copper in diet to &lt;1-2 mg/day and omit chocolate, nuts, shellfish, mushrooms, liver, raisins, broccoli, copper-enriched cereal, multivitamins with copper, and molasses. May consider short courses of iron supplementation if dietary modifications (eg, low copper diet in Wilson&rsquo;s disease, low methionine diet in cystinuria) results in iron deficiency; pediatric patients and menstruating women may be particularly susceptible to iron deficiency.  Allow 2 hours between administration of iron supplementation and penicillamine as iron may decrease drug absorption. For cystinuria, increase daily fluid intake including 1 pint (~500 mL) of fluid prior to bedtime and 1 additional pint during the night. For lead poisoning, decrease calcium in diet.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F207463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Cuprimine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $1065.08",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Depen Titratabs Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $767.96",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F207451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urinalysis, CBC with differential, platelet count, skin, lymph nodes, and body temperature twice weekly during the first month of therapy, then every 2 weeks for 5 months, then monthly; LFTs every 6 months; signs/symptoms of hypersensitivity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cystinuria: Urinary cystine, annual X-ray for renal stones",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lead poisoning: Serum lead concentration (baseline and 7-21 days after completing chelation therapy); hemoglobin or hematocrit, iron status, free erythrocyte protoporphyrin or zinc protoporphyrin; neurodevelopmental changes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Wilson's disease: Serum non-ceruloplasmin bound copper, 24-hour urinary copper excretion, LFTs every 3 months (at least) during the first year of treatment; periodic ophthalmic exam",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Urinalysis: Monitor for proteinuria and hematuria. A quantitative 24-hour urine protein at 1- to 2-week intervals initially (first 2-3 months) is recommended if proteinuria develops.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F9882125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Wilson's disease: 24-hour urinary copper excretion: 200-500 mcg (3-8 micromoles)/day",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F207466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adalken (MX);",
"     </li>",
"     <li>",
"      Artamin (AT, CY, KP, MY, PL);",
"     </li>",
"     <li>",
"      Atamir (DK);",
"     </li>",
"     <li>",
"      Byanodine (HU);",
"     </li>",
"     <li>",
"      Cilamin (IN);",
"     </li>",
"     <li>",
"      Cuprenil (BG, HN, PL);",
"     </li>",
"     <li>",
"      Cuprimine (MY, NL, NO, TH, TW);",
"     </li>",
"     <li>",
"      Cuprimune (AR, BR);",
"     </li>",
"     <li>",
"      Cupripen (CO, ES, UY);",
"     </li>",
"     <li>",
"      D-Penamine (AU, NZ);",
"     </li>",
"     <li>",
"      D-Penil (PE);",
"     </li>",
"     <li>",
"      Distamine (GB, IE, NL);",
"     </li>",
"     <li>",
"      Kelatin (BE, LU, NL);",
"     </li>",
"     <li>",
"      Kelatine (PT);",
"     </li>",
"     <li>",
"      Mercaptyl (CH);",
"     </li>",
"     <li>",
"      Metalcaptase (DE, HR, JP, LU);",
"     </li>",
"     <li>",
"      Metalcaptase[inj.] (CZ, HR);",
"     </li>",
"     <li>",
"      Pemine (IT);",
"     </li>",
"     <li>",
"      Penicilamin (CZ);",
"     </li>",
"     <li>",
"      Penicilamina (CN);",
"     </li>",
"     <li>",
"      Penicillamin (FI, SE);",
"     </li>",
"     <li>",
"      Reumacillin (FI);",
"     </li>",
"     <li>",
"      Sufortanon (ES);",
"     </li>",
"     <li>",
"      Trisorcin (HR);",
"     </li>",
"     <li>",
"      Trolovol (FR, HR);",
"     </li>",
"     <li>",
"      Vistamin (PK)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F207441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Chelates with lead, copper, mercury and other heavy metals to form stable, soluble complexes that are excreted in urine; depresses circulating IgM rheumatoid factor, depresses T-cell but not B-cell activity; combines with cystine to form a compound which is more soluble, thus cystine calculi are prevented",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F207460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Rheumatoid arthritis: 2-3 months; Wilson's disease: 1-3 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid but incomplete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;80% to albumin and ceruloplasmin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (small amounts metabolized to s-methyl-d-penicillamine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 40% to 70%; reduced by food, antacids, and iron",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 1.7-7 hours (Roberts, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 1-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (primarily as disulfides)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Adelman HM, Winters PR, Mahan CS, et al, &ldquo;D-Penicillamine-Induced Myasthenia Gravis; Diagnosis Obscured by Coexisting Chronic Obstructive Pulmonary Disease,&rdquo;",
"      <i>",
"       Am J Med Sci",
"      </i>",
"      , 1995, 309(4):191-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7900739/pubmed\" id=\"7900739\" target=\"_blank\">",
"        7900739",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Albert C, Aynard B, Terbe V, et al, &ldquo;D-Penicillamine Induced Rapidly Progressive Glomerulonephritis With Membranous Nephropathy in a Patient With Rheumatoid Arthritis,&rdquo;",
"      <i>",
"       Clin Exp Rheumatol",
"      </i>",
"      , 1994, 12(Suppl 11):108.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Environmental Health, &ldquo;Lead Exposure in Children: Prevention, Detection, and Management,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2005, 116(4):1036-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/16199720/pubmed\" id=\"16199720\" target=\"_blank\">",
"        16199720",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Andonopoulos AP, Terzis E, and Tsibri E, &ldquo;D-Penicillamine Induced Myasthenia Gravis in Rheumatoid Arthritis: An Unpredictable Common Occurrence?&rdquo;",
"      <i>",
"       Clin Rheumatol",
"      </i>",
"      , 1994, 13(4):586-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7697959/pubmed\" id=\"7697959\" target=\"_blank\">",
"        7697959",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 104.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronow R and Fleschmann LE, &ldquo;Mercury Poisoning in Children,&rdquo;",
"      <i>",
"       Clin Pediatr (Phila)",
"      </i>",
"      , 1976, 15(10):936-45.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC),",
"      <i>",
"       Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women",
"      </i>",
"      , Atlanta: CDC; 2010.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Interpreting and Managing Blood Lead Levels &lt;10 microg/dL in Children and Reducing Childhood Exposures to Lead: Recommendations of CDC's Advisory Committee on Childhood Lead Poisoning Prevention,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2007, 56(RR-8):1-16.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/17975528/pubmed\" id=\"17975528\" target=\"_blank\">",
"        17975528",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC),",
"      <i>",
"       Managing Elevated Blood Lead Levels Among Young Children: Recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention",
"      </i>",
"      , Atlanta: CDC; 2002.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chandran L and Cataldo R, &ldquo;Lead Poisoning: Basics and New Developments,&rdquo;",
"      <i>",
"       Pediatr Rev",
"      </i>",
"      , 2010, 31(10):399-406.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/20889734/pubmed\" id=\"20889734\" target=\"_blank\">",
"        20889734",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cullen NM, Wolf LR, and St Clair D, &ldquo;Pediatric Arsenic Ingestion,&rdquo;",
"      <i>",
"       Am J Emerg Med",
"      </i>",
"      , 1995, 13(4):432-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7605532/pubmed\" id=\"7605532\" target=\"_blank\">",
"        7605532",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gracia RC and Snodgrass WR, &ldquo;Lead Toxicity and Chelation Therapy,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2007, 64(1):45-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/17189579/pubmed\" id=\"17189579\" target=\"_blank\">",
"        17189579",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hryhorczuk DO, Meyers L, and Chen G, &ldquo;Treatment of Mercury Intoxication in a Dentist With N-Acetyl-D,L-Penicillamine,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1982, 19(4):401-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7143525/pubmed\" id=\"7143525\" target=\"_blank\">",
"        7143525",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kandola L, Swannell AJ, and Hunter A, &ldquo;Acquired Sideroblastic Anaemia Associated With Penicillamine Therapy for Rheumatoid Arthritis,&rdquo;",
"      <i>",
"       Ann Rheum Dis",
"      </i>",
"      , 1995, 54(6):529-30.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kosnett MJ, Wedeen RP, Rothenberg SJ, et al, &ldquo;Recommendations for Medical Management of Adult Lead Exposure,&rdquo;",
"      <i>",
"       Environ Health Perspect",
"      </i>",
"      , 2007, 115(3):463-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/17431500/pubmed\" id=\"17431500\" target=\"_blank\">",
"        17431500",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lifshitz M and Levy J, &ldquo;Efficacy of D-Penicillamine in Reducing Lead Concentrations in Children: A Prospective, Uncontrolled Study,&rdquo;",
"      <i>",
"       J Pharm Technol",
"      </i>",
"      , 2000, 16(3):98-101.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lyle WH, &ldquo;Penicillamine in Metal Poisoning,&rdquo;",
"      <i>",
"       J Rheumatol Suppl",
"      </i>",
"      , 1981, 7:96-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/6939892/pubmed\" id=\"6939892\" target=\"_blank\">",
"        6939892",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Multz CV, &ldquo;Cholestatic Hepatitis Caused by Penicillamine,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1981, 246(6):674-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7253120/pubmed\" id=\"7253120\" target=\"_blank\">",
"        7253120",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Negishi M, Matsuda A, Kaga S, et al, &ldquo;A Case of Agranulocytosis Which Occurred Several Hours After the Readministration of D-Penicillamine Accompanied by Shivering-Chillness,&rdquo;",
"      <i>",
"       Arerugi",
"      </i>",
"      , 1995, 44(2):96-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7726755/pubmed\" id=\"7726755\" target=\"_blank\">",
"        7726755",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Oga M, Matsui N, Anai T, et al, &ldquo;Copper Disposition of the Fetus and Placenta in a Patient With Untreated Wilson's Disease,&rdquo;",
"      <i>",
"       Am J Obstet Gynecol",
"      </i>",
"      , 1993, 169(1):196-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/8333453/pubmed\" id=\"8333453\" target=\"_blank\">",
"        8333453",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Piomelli S, &ldquo;Childhood Lead Poisoning,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 2002, 49(6):1285-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/12580366/pubmed\" id=\"12580366\" target=\"_blank\">",
"        12580366",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roberts EA and Schilsky ML, &ldquo;Diagnosis and Treatment of Wilson Disease: An Update. American Association for Study of Liver Diseases (AASLD),&rdquo;",
"      <i>",
"       Hepatology",
"      </i>",
"      , 2008, 47(6):2089-111.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/18506894/pubmed\" id=\"18506894\" target=\"_blank\">",
"        18506894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rosa FW, &ldquo;Teratogen Update. Penicillamine,&rdquo;",
"      <i>",
"       Teratology",
"      </i>",
"      , 1986, 33(1):127-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/3738805/pubmed\" id=\"3738805\" target=\"_blank\">",
"        3738805",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rosenberg AM. &ldquo;Advanced Drug Therapy for Juvenile Rheumatoid Arthritis,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1989, 114(2):171-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/2563402/pubmed\" id=\"2563402\" target=\"_blank\">",
"        2563402",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shannon M and Townsend MK, &ldquo;Adverse Effects of Reduced-Dose d-Penicillamine in Children With Mild to Moderate Lead Poisoning,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1999, 37(5):625.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith DB and Gallagher BB, &ldquo;The Effect of Penicillamine on Seizure Threshold. The Role of Pyridoxine,&rdquo;",
"      <i>",
"       Arch Neurol",
"      </i>",
"      , 1970, 23(1):59-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/5421930/pubmed\" id=\"5421930\" target=\"_blank\">",
"        5421930",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stein HB, Patterson AC, Offer RC, et al, &ldquo;Adverse Effects of D-Penicillamine in Rheumatoid Arthritis,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1980, 92:24-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7350870/pubmed\" id=\"7350870\" target=\"_blank\">",
"        7350870",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Swarup A, Sachdeva N, and Schumacher Jr HP, &ldquo;Dosing of Antirheumatic Drugs in Renal Disease and Dialysis,&rdquo;",
"      <i>",
"       J Clin Rheumatol",
"      </i>",
"      , 2004, 10(4):190-204.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/17043508/pubmed\" id=\"17043508\" target=\"_blank\">",
"        17043508",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Treatment Guidelines for Lead Exposure in Children. American Academy of Pediatrics Committee on Drugs,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1995, 96(1 Pt 1):155-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/6/4200/abstract-text/7596706/pubmed\" id=\"7596706\" target=\"_blank\">",
"        7596706",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9747 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.181.191-9843F0D5B8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4200=[""].join("\n");
var outline_f4_6_4200=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709199\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207480\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207481\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207525\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207484\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207504\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207485\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207486\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13804101\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207453\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207438\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207457\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207456\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207532\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207523\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207461\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207442\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299837\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207447\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207475\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207449\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207464\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207490\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207465\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207463\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207451\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9882125\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207466\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207441\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207460\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9747\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9747|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?33/20/34117?source=related_link\">",
"      Penicillamine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/26/6566?source=related_link\">",
"      Penicillamine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_6_4201="Ovulation induction with aromatase inhibitors";
var content_f4_6_4201=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ovulation induction with aromatase inhibitors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Robert F Casper, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Mohamed FM Mitwally, MD, HCLD, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/6/4201/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/6/4201/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with anovulatory infertility can be categorized based on their gonadotropin status as defined by the World Health Organization (WHO): WHO I refers to hypogonadotropic hypogonadism, WHO II refers to eugonadotropic, and WHO III refers to hypergonadotropic hypogonadism. Women with WHO II anovulatory infertility, most of whom have polycystic ovary syndrome, typically have normal follicular phase estrogen levels and withdrawal uterine bleeding after a progestin challenge.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     Clomiphene",
"    </a>",
"    citrate (CC) is the most commonly used pharmacologic agent to induce ovulation in these women, but some women fail to conceive with this therapy. During the past decade, both insulin sensitizers, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , and aromatase inhibitors have been used for ovulation induction in women who fail to conceive with CC. Aromatase inhibitors are a class of drugs that block estrogen biosynthesis, thereby reducing negative estrogenic feedback at the pituitary.",
"   </p>",
"   <p>",
"    This topic review discusses studies on the experimental use of aromatase inhibitors for ovulation induction in women with WHO II anovulatory infertility. However, at this time, use of aromatase inhibitors for ovulation induction in premenopausal women is controversial due to the possibility of fetal toxicity and fetal malformations raised by one abstract [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/1\">",
"     1",
"    </a>",
"    ]. However, two subsequent publications have shown no evidence of fetal malformations with the aromatase inhibitor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    and no difference in birthweight compared to spontaneous conceptions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , and gonadotropins is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link\">",
"     \"Ovulation induction with clomiphene citrate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY AND PHARMACOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Aromatase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aromatase is a microsomal cytochrome P450 hemoprotein-containing enzyme (P450arom, the product of the CYP19 gene) that catalyzes the rate-limiting step in the production of estrogens: the conversion of androstenedione and testosterone via three hydroxylation steps to estrone and estradiol, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/4\">",
"     4",
"    </a>",
"    ]. It is a good target for selective inhibition because estrogen production is a terminal step in the biosynthetic sequence. Aromatase activity is present in many tissues, including the ovaries, brain, adipose tissue, muscle, liver, and breast.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Aromatase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aromatase inhibitors are available for clinical use in North America, Europe, and other parts of the world for treatment of postmenopausal breast cancer, but not for ovulation induction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link\">",
"     \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     Letrozole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    are triazole (antifungal) derivatives that are potent, reversible, competitive, nonsteroidal aromatase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. At doses of 1 to 5",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    these drugs inhibit estrogen levels by 97 to &gt;99 percent, resulting in estrogen concentrations below the level detected by most sensitive immunoassays. Nonsteroidal aromatase inhibitors are completely absorbed after oral administration and have a mean terminal half-life of approximately 45 hours (range, 30 to 60 hours); clearance is mainly hepatic. By comparison,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/4/7238?source=see_link\">",
"     exemestane",
"    </a>",
"    is a steroidal aromatase inhibitor. It has a circulating half-life of approximately nine hours, but the inhibitory effect is potentially much longer because its effect on aromatase is irreversible [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aromatase inhibitors are generally well tolerated. The main side effects are hot flushes and gastrointestinal events (nausea and vomiting), headache, back pain, and leg cramps [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/6,8,9\">",
"     6,8,9",
"    </a>",
"    ]. These adverse effects were reported in older women with advanced breast cancer who were given the drugs on a daily basis over several months in first- or second-line comparative Phase III trials. Very few withdrew from the trials because of drug-related adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In our clinical experience using a short course of aromatase inhibitor for induction of ovulation in young healthy women, there have been fewer side effects than with CC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Rationale for use in ovulation induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both circulating estrogen and locally produced estrogen in the brain exert negative feedback on the release of gonadotropins [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. Inhibition of aromatization should block estrogen production from all sources and release the",
"    <span class=\"nowrap\">",
"     hypothalamic/pituitary",
"    </span>",
"    axis from this negative feedback. The resultant increase in gonadotropin secretion should stimulate growth of ovarian follicles. As the dominant follicle grows and estrogen levels rise, normal negative feedback occurs centrally because aromatase inhibitors do not deplete estrogen receptors (ER) in the brain. FSH is suppressed and the smaller growing follicles become atretic. Mono-ovulation of a single dominant follicle should occur in most cases (",
"    <a class=\"graphic graphic_figure graphicRef81745 \" href=\"UTD.htm?5/14/5347\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In women with polycystic ovary syndrome (PCOS), relative over-suppression of FSH may be the result of excessive androgen produced from the ovary being converted to estrogen by aromatization in the brain. The aromatase inhibitors suppress estrogen production in both the ovaries and the brain. Therefore, in women with PCOS, aromatase inhibitors should produce a robust increase in FSH release and subsequent follicle stimulation and ovulation. The actual FSH release is likely to be blunted by the high levels of circulating inhibin found in PCOS patients, which would not be altered by aromatase inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Since aromatase inhibition does not antagonize ER in the brain, the initiation of follicle growth accompanied by increasing concentrations of both estradiol and inhibin results in a normal negative feedback loop that limits FSH response, thereby avoiding the risk of high multiple ovulation and ovarian hyperstimulation syndrome (OHSS).",
"   </p>",
"   <p>",
"    A second hypothesis for the mechanism of action of the aromatase inhibitors in ovarian stimulation involves increased follicular sensitivity to FSH. This could result from temporary accumulation of intraovarian androgens, since conversion of androgen substrate to estrogen is blocked by aromatase inhibition. Androgens appear to play a role in early follicular growth in primates [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/20\">",
"     20",
"    </a>",
"    ]. Testosterone augments follicular FSH receptor expression in primates, suggesting that androgens promote follicular growth and estrogen biosynthesis indirectly by amplifying FSH effects [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Also, androgen accumulation in the follicle stimulates insulin-like growth factor I (IGF-I), which may synergize with FSH to promote folliculogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/23-26\">",
"     23-26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is possible that women with PCOS already have a relative aromatase deficiency in the ovary leading to increased intraovarian androgens that causes the development of multiple small follicles responsible for the polycystic morphology of the ovaries [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The androgens, as described above, may also increase FSH receptors making these PCOS ovaries exquisitely sensitive to an increase in FSH either through exogenous administration of gonadotropins (hence the high risk of OHSS), or through endogenous increases in FSH as a result of decreased central estrogen feedback induced by aromatase inhibition. In the latter case, a relatively small rise in FSH, because of a normal",
"    <span class=\"nowrap\">",
"     inhibin/estrogen",
"    </span>",
"    feedback loop, generally leads to monofollicular ovulation, thus avoiding the occurrence of OHSS.",
"   </p>",
"   <p>",
"    For these reasons, an aromatase inhibitor used alone should result in development of one or two mature follicles and a significantly reduced risk for ovarian hyperstimulation and multiple gestation. The addition of FSH to the aromatase inhibitor is probably necessary to achieve multiple ovulation, which is desirable when oocytes are harvested for in vitro fertilization.",
"   </p>",
"   <p>",
"    In addition, and in contrast to CC which blocks estrogen action not synthesis, aromatase inhibitors do not deplete estrogen receptors (ER) at target organs. Thus, these drugs can potentially be useful in women with WHO II type infertility who fail to conceive with CC therapy. The probable explanation for the absence of pregnancy in these women, despite evidence of ovulation, is that CC exerts antiestrogenic effects on peripheral estrogen targets (endocervix and endometrium) by depleting estrogen receptors (ER) at these sites. This hypothesis is supported by the observation that these women typically have a thin endometrium, less than 6 mm, on transvaginal ultrasound examination and impaired quality or quantity of cervical mucus [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/29-34\">",
"     29-34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link\">",
"     \"Ovulation induction with clomiphene citrate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVIDENCE OF EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence supporting the use of aromatase inhibitors in ovulation induction for infertility treatment has been accumulating, but there are no large scale head to head clinical trials of aromatase inhibitors versus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    for ovulation induction in WHO II women [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. Most of the studies used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    , but",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    has also been used [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. It is not known whether there are any clinically significant pharmacological differences between letrozole and anastrozole with respect to efficacy of ovulation induction [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Examples of studies illustrating the value of aromatase inhibitors for inducing ovulation are provided below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We performed an early proof of concept study in women with PCOS who had a failed response to CC, defined as failed ovulation induction determined by serial ultrasound and serum estradiol and LH monitoring, or as ovulation with a very thin mid-cycle endometrium (&lt;0.5 cm) as a result of peripheral anti-estrogenic effects of CC [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. These patients were offered the option of trying",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      as an alternative treatment for induction of ovulation. During letrozole treatment, ovulation occurred in 9 of 12 PCOS patients, including three of four patients who were anovulatory with CC. Pregnancy was achieved in three cycles, two of which were singleton clinical pregnancies and one was a chemical pregnancy.",
"     </li>",
"     <li>",
"      A prospective, randomized controlled trial assessed CC versus an aromatase inhibitor for augmentation of ovulation in 50 women with unexplained infertility who were undergoing intrauterine insemination (IUI) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/35\">",
"       35",
"      </a>",
"      ]. Ovulatory infertile patients were randomly assigned to receive CC (100 mg) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      (2.5 mg) daily from days 3 to 7. The mean number of preovulatory follicles in CC and letrozole groups was two and one, respectively. Estradiol levels on the day of hCG administration were significantly higher in the CC group compared with the letrozole group (627",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      versus 163",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      [2300 versus 600",
"      <span class=\"nowrap\">",
"       pmol/L])",
"      </span>",
"      while endometrial thickness and blood flow were significantly lower with CC (6.9 mm and pulsatility index (PI) of 3.6) compared to letrozole (8.6 mm and PI of 3.1). However, the difference in pregnancy rates did not reach statistical significance (CC 5.6 percent, letrozole 16.7 percent).",
"     </li>",
"     <li>",
"      A retrospective cohort study compared pregnancy rates after",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      versus gonadotropin administration in 52 women who failed to conceive with CC [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/46\">",
"       46",
"      </a>",
"      ]. Among women who failed at least three cycles of CC, use of gonadotropins resulted in a significantly higher rate of pregnancy (33 versus 9 percent) and detection of a fetal heart beat (26 versus 7 percent) than letrozole; these benefits were not observed among women with fewer than three cycles of CC. There were two multiple gestations in the gonadotropin group and none in the letrozole group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to point out that an aromatase inhibitor is unlikely to be successful in cases of CC resistance due to severe insulin resistance or the use of CC for inappropriate indications (eg, hypothalamic amenorrhea or ovarian failure). The correction of insulin resistance with an insulin sensitizer is the logical approach in patients with insulin resistance. Alternative treatments should be considered for other problems, such as exogenous gonadotropin injection in patients with hypogonadotropic hypogonadism (WHO II) and oocyte donation for women with ovarian failure (WHO III). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL USE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ovulation induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aromatase inhibitors may replace",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    citrate in the future because of similar efficacy with a reduced side effect profile [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/47\">",
"     47",
"    </a>",
"    ]. At this time, however, use of aromatase inhibitors for ovulation induction in premenopausal women is controversial due to the potential for fetal toxicity and fetal malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The following discussion relates to research protocols.",
"   </p>",
"   <p>",
"    The optimal dose of aromatase inhibitor for ovulation induction is unclear. In most studies, the dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    (2.5 mg) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    (1 mg) was that typically used for breast cancer treatment in postmenopausal women. However, a randomized study that compared 2.5 and 5 mg of letrozole in women with regular cycles, tubal patency, and no male factor reported a significantly higher number of follicles and a significantly higher pregnancy rate with the 5 mg dose (pregnancy rate per cycle: 26.3 versus 5.9 percent); endometrial thickness was the same in both dosage groups [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/48\">",
"     48",
"    </a>",
"    ]. Another study using 7.5 mg of letrozole from cycle days 3 to 7 showed a thinning of the endometrium similar to CC [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on these data, it is likely that the optimal dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    for a five-day course of treatment is between 2.5 and 5 mg, with higher doses resulting in persistence of aromatase inhibition and estrogen levels too low for normal endometrial development by the time of ovulation. For",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    , there is insufficient data to determine the preferred dose, although it appears that the standard 1 mg dose is too low for good follicle recruitment and ovulation; doses in the range of 5 mg may be optimal [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one randomized trial, women with PCOS who had not become pregnant with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    were randomly assigned to either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    2.5 mg daily or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    , 1 mg daily, for cycle days 3 to 7 [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/39\">",
"     39",
"    </a>",
"    ]. The ovulation rate was significantly greater in the letrozole than the anastrozole group (84 versus 60 percent) and the pregnancy rate was greater in the letrozole group (27 versus 17 percent).",
"   </p>",
"   <p>",
"    In the studies described above, an aromatase inhibitor was administered orally as a repeated daily dose, generally from days 3 to 7 of the menstrual cycle. Based on the pharmacokinetics of the third generation aromatase inhibitors (almost 100 percent bioavailability after oral administration, half-life two days, and no accumulation or significant metabolite accumulation), we hypothesized that administration of a high single dose of the aromatase inhibitor early in the menstrual cycle would have several advantages. Early single dose administration would achieve maximum estrogen suppression early in the menstrual cycle when it is desired; it would allow more rapid clearance of the aromatase inhibitor before the critical final stage of fertilization and embryogenesis, to maximize safety; and it would be convenient and perhaps improve compliance with treatment.",
"   </p>",
"   <p>",
"    We chose a 20 mg dose based on calculations of prior pharmacokinetics [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/49,50\">",
"     49,50",
"    </a>",
"    ] and estimated that the therapeutic level of aromatase inhibition after this dose should last about five days and that clearance should occur completely by day 13. By comparison, the total dose in the five day regimen is 12.5 mg. We found that a single 20 mg dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    had the same ovulation induction rate, the same cycle characteristics in terms of day of the LH surge or hCG administration, the same estradiol levels on the day of hCG, the same number of follicles generated, and the same pregnancy rate as the multidose regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/51\">",
"     51",
"    </a>",
"    ]. Consistent with our results, another study that compared a single dose of 25 mg letrozole on cycle day 3 to doses of 5 mg given daily from cycle days 3 to 7 reported that the single dose resulted in similar follicle recruitment, endometrial thickness, hormonal levels, and side effects as the multiple-dose regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Controlled ovarian hyperstimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;We investigated the idea of combining an aromatase inhibitor with gonadotropin injection to reduce the dose of FSH required to achieve optimal controlled ovarian stimulation (COH), without adverse antiestrogenic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/53-55\">",
"     53-55",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     Letrozole",
"    </a>",
"    2.5 mg was given from cycle days 3 to 7 and FSH was added on cycle day 7 until induction of ovulation with hCG (sequential regimen). The FSH dose required was 45 to 55 percent lower than with standard regimens and there were no peripheral antiestrogenic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/42,43,53,56\">",
"     42,43,53,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another study including women with unexplained infertility and mild male factor infertility, we compared the use of an aromatase inhibitor plus FSH (36 women, 42 cycles) to the use of CC plus FSH (18 women, 19 cycles) or to FSH alone (56 women, 91 cycles) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/54\">",
"     54",
"    </a>",
"    ]. Co-treatment with an aromatase inhibitor in a sequential regimen significantly reduced the FSH dose required during COH, to the same extent as did CC. The aromatase inhibitor was not associated with antiestrogenic effects as demonstrated by the significantly lower endometrial thickness noted with CC treatment despite the significantly higher E2 level. In addition, the pregnancy rate with an aromatase inhibitor and FSH was equivalent to FSH alone, and almost twice the level seen with CC and FSH treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A third study used a dose of 5 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    together with FSH in an overlapping regimen (ie, starting the FSH treatment on the third day of the fifth day aromatase inhibitor treatment) for superovulation in women undergoing intrauterine insemination [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/56\">",
"     56",
"    </a>",
"    ]. Compared to FSH treatment alone, the combination of letrozole and FSH resulted in a reduction of gonadotropin dose, similar pregnancy rates, but a slight negative effect on endometrial thickness, likely because the overlapping regimen advanced follicle growth and ovulation and did not allow time for clearance of the larger dose of letrozole by the time of hCG administration.",
"   </p>",
"   <p>",
"    It is known that the cost of gonadotropin injections constitutes a significant part of the expense of infertility treatment, especially during assisted reproduction. As a result of studies examining FSH together with an aromatase inhibitor, we believe that the aromatase inhibitors will markedly reduce the cost of infertility treatment by decreasing the FSH dose required for optimum ovarian stimulation. This could make assisted reproductive technology available to a larger group of infertile couples.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Poor responders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reduction in the required dose of FSH observed in conjunction with an aromatase inhibitor encouraged us to explore the use of an aromatase inhibitor to improve response to ovarian stimulation with FSH in poor responders. In an observational cohort study, 12 patients with unexplained infertility and a poor response to ovarian stimulation with FSH in at least two cycles (total of 25 cycles of FSH-only stimulation) were offered",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    as an adjuvant treatment with FSH injection to improve ovarian response to FSH stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/53\">",
"     53",
"    </a>",
"    ]. These women were undergoing COH for intrauterine insemination and poor response was defined as less than three follicles &gt;1.8 cm in diameter on the day of the LH surge or hCG administration. Letrozole 2.5 mg was given from days 3 to 7 after onset of menses and FSH injection was started on day 7 of the menstrual cycle at a dose of 50 to 225",
"    <span class=\"nowrap\">",
"     IU/day,",
"    </span>",
"    depending on the number of developing follicles seen on ultrasound. The aim was to achieve three preovulatory follicles on the day of hCG injection.",
"   </p>",
"   <p>",
"    During FSH plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    stimulation cycles, the mean number of mature follicles was significantly higher than in FSH-only stimulation cycles (3.3 versus 1.9 follicles). The amount of FSH required was significantly lower in the letrozole plus FSH cycles than in the FSH-only cycles (616 &plusmn; 454 IU versus 1590 &plusmn; 708 IU, respectively). There was no significant difference between FSH only or letrozole plus FSH in endometrial thickness on the day of hCG administration, indicating the absence of any antiestrogenic effects of letrozole on the endometrium. Three of the women conceived a clinical pregnancy with combined letrozole plus FSH treatment.",
"   </p>",
"   <p>",
"    In this clinical trial, we demonstrated a benefit of aromatase inhibition in improving ovarian response to FSH stimulation in poor responders. The improved response was clearly shown by the significantly higher number of mature follicles and significantly lower amount of FSH needed to achieve an adequate number of preovulatory follicles. In addition, the endometrium sustained implantation as demonstrated by three clinical pregnancies in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    plus FSH cycles.",
"   </p>",
"   <p>",
"    Other studies have suggested the value of aromatase inhibitors in poor responders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An uncontrolled series of poor responders (27 patients) reported a significant benefit from adding an aromatase inhibitor to the stimulation protocol (GnRH",
"      <span class=\"nowrap\">",
"       antagonist/",
"       <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"        letrozole",
"       </a>",
"       /FSH",
"      </span>",
"      protocol) after failing microdose agonist flare stimulation protocol [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized, controlled study compared an aromatase inhibitor plus FSH protocol with a standard GnRH agonist and FSH protocol in poor responders undergoing IVF [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/58\">",
"       58",
"      </a>",
"      ]. Although this was a small pilot study including only 38 patients, the results suggested that the addition of an aromatase inhibitor to a small dose of FSH (150 IU; two injections of 75 IU on cycle days 3 and 8) resulted in a similar number of oocytes retrieved, embryos transferred and pregnancy rate as observed in the women on the standard protocol receiving a mean (&plusmn; SEM) of 2865 &plusmn; 228 IU of FSH. Aromatase inhibitors could be a low cost alternative to natural cycle IVF in patients who are poor responders to FSH, but larger randomized studies are required to confirm these data.",
"     </li>",
"     <li>",
"      A prospective observational study evaluated the use of an aromatase inhibitor as an adjuvant to FSH treatment in IVF cycles of poor responder patients with at least one previously canceled IVF cycle [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/59\">",
"       59",
"      </a>",
"      ]. The control group consisted of 76 patients treated with high dose gonadotropins in a GnRH-antagonist regimen while the experimental group of 71 patients received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      2.5 mg plus gonadotropins for the first five days of stimulation followed by the same",
"      <span class=\"nowrap\">",
"       gonadotropin/antagonist",
"      </span>",
"      regimen. Patients receiving an aromatase inhibitor had higher numbers of oocytes retrieved and had a higher implantation rate despite receiving the same doses of",
"      <span class=\"nowrap\">",
"       FSH/",
"      </span>",
"      hMG as the control group. Both testosterone and androstenedione were significantly increased in concentration in the follicular fluid in the experimental group compared with the control group. These findings are consistent with the hypothesis that aromatase inhibition, by blocking androgen to estrogen conversion, increases intraovarian androgens and follicular FSH receptor expression and sensitivity to FSH administration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Women with breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is desirable to avoid elevated estrogen levels during ovarian stimulation in women with breast cancer undergoing infertility treatment. For this reason, aromatase inhibitors may be particularly useful for inducing ovulation in women with breast cancer. Aromatase inhibition is associated with significantly lower serum estrogen levels at midcycle than seen with CC [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/45,54\">",
"     45,54",
"    </a>",
"    ]. The rapid clearance of the aromatase inhibitors, the reversible nature of enzyme inhibition, and elevated levels of FSH, which induces new expression of aromatase enzyme, are factors that likely result in estrogen production that appears to be relatively normal, rather than elevated, at the time of ovulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=see_link\">",
"     \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PREGNANCY ISSUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;Published studies have not observed teratogenic effects from exposure to aromatase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], although there is some controversy in this regard [",
"    <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/1,60\">",
"     1,60",
"    </a>",
"    ]. At this time, all aromatase inhibitors should be used with caution for ovulation induction in premenopausal women since this is an off-label indication.",
"   </p>",
"   <p>",
"    Based on the half-life of each drug, administration in the early follicular phase should result in clearance of the aromatase inhibitors before implantation takes place. Nevertheless, care should be taken in all cases of ovulation induction with these drugs to ensure that the patient is not pregnant prior to administration. We suggest a blood hCG level be ascertained before using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    in premenopausal women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several large studies have assessed pregnancy outcome after infertility treatment with aromatase inhibitors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A cohort study compared the outcome of pregnancies achieved after",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      and other ovarian stimulation treatments with a control group of pregnancies spontaneously conceived without ovarian stimulation in three tertiary referral centers over a two-year period [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/61\">",
"       61",
"      </a>",
"      ]. There were 394 pregnancy cycles in 345 infertile couples (133 pregnancies with 2.5 mg or 5 mg letrozole alone or with gonadotropins, 113 pregnancies with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      alone or with gonadotropins, 110 pregnancies with gonadotropins alone, and 38 pregnancies achieved without ovarian stimulation). Pregnancies conceived after aromatase inhibitor treatment had similar miscarriage and ectopic pregnancy rates compared to all other groups. In addition, letrozole use was associated with a significantly lower rate of multiple-gestation compared to CC (4.3 percent versus 22 percent, respectively), consistent with our hypothesis of an intact negative feedback loop centrally with aromatase inhibition.",
"     </li>",
"     <li>",
"      Another study, presented as an abstract at the American Society of Reproductive Medicine in 2005, compared the outcome of 150 births after treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      to outcomes in a database of 36,050 normal deliveries [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/1\">",
"       1",
"      </a>",
"      ]. There was not a statistically significant difference in the overall incidence of congenital malformations for the two groups (95% CI 0.78-4.71); however, letrozole-induced pregnancies had a higher incidence of locomotor malformations (95% CI 2.64-27.0) and cardiac anomalies (95% CI 3.30-58.1). The authors concluded that use of letrozole in ovulation induction should be curtailed until more data on outcomes of pregnancies are obtained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A careful review of the abstract demonstrates major methodological flaws that weaken the data and the conclusions presented. First, the study was not well controlled. Treated patients (n = 130) were women with a mean age of 35.2 years presenting with polycystic ovarian syndrome or unexplained infertility. The controls were taken from a database of spontaneously conceiving women (n = 36,050), mean age 30.5 years, presenting to a low-risk hospital. This is an important distinction because women of advanced maternal age (AMA) have an increased incidence of medical illnesses and medication use thus making their pregnancies higher risk. Medical illnesses, such as type 2 diabetes are more prevalent in AMA and can be associated with a higher incidence of fetal malformations. Also, the incidence of multiple gestations was higher in the treated group compared to controls. It is well known that multiple gestations are at increased risk of fetal malformations compared to singleton pregnancies.",
"   </p>",
"   <p>",
"    The authors stated that the incidence of malformations was not different between the two groups, but they went on to report that there was a higher incidence of locomotor malformations. The authors did not address the definition of locomotor malformations and how it was assessed. Additionally, the abstract reported a higher incidence of cardiac anomalies in the experimental group. A low incidence of cardiac anomalies in a low-risk hospital setting is not surprising since mothers would be transferred to a tertiary-care center once such an in utero anomaly was detected.",
"   </p>",
"   <p>",
"    Finally, given that the half-life of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    is 45 hours and the drug is only taken until day 5 of the menstrual cycle (with fertilization occurring approximately 10 days later), the biological plausibility of the results presented in this study are unlikely.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A subsequent series compared the incidence of congenital malformations in 911 newborns of women who conceived following treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      citrate and did not find a statistically significant difference [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/2\">",
"       2",
"      </a>",
"      ]. Congenital malformations were diagnosed in",
"      <span class=\"nowrap\">",
"       14/514",
"      </span>",
"      (2.4 percent) newborns in the letrozole group versus",
"      <span class=\"nowrap\">",
"       19/397",
"      </span>",
"      (4.8 percent) newborns in the clomiphene group, the rates of major malformations were",
"      <span class=\"nowrap\">",
"       6/514",
"      </span>",
"      (1.2 percent) and",
"      <span class=\"nowrap\">",
"       12/397",
"      </span>",
"      (3.0 percent), respectively. These differences were not statistically significant. However, there was a sevenfold increase in overall cardiac anomalies in the clomiphene citrate group compared with the letrozole-treated group (p = 0.02). The authors concluded that concerns about the teratogenicity of letrozole in the setting of ovulation induction were unfounded.",
"     </li>",
"     <li>",
"      A follow-up study by the Motherisk Program at the Hospital for Sick Children in Toronto found no increase in congenital anomalies with either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"       letrozole",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      compared to a control group of spontaneous conceptions, but did observe a significant increase in low birth weight babies with use of clomiphene [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/3\">",
"       3",
"      </a>",
"      ]. Babies born after use of letrozole were similar in birth weight to the spontaneous conception babies.",
"     </li>",
"     <li>",
"      A multicenter case-control study, the National Birth Defects Prevention Study of the Centers for Disease Control, examined the risk of 30 different birth defects in women who took",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      citrate at any time during the two months before conception through the first month of pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/6/4201/abstract/62\">",
"       62",
"      </a>",
"      ]. Several associations between CC exposure and birth defects were found. These findings are inconsistent with previous studies of clomiphene exposure and pregnancy outcome and should be interpreted with caution; they are based upon a small number of cases, and the investigators were unable to assess the effects of clomiphene separately from the effects of subfertility. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link&amp;anchor=H20#H20\">",
"       \"Ovulation induction with clomiphene citrate\", section on 'Pregnancy and perinatal outcome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preliminary studies have demonstrated that aromatase inhibitors are effective for ovulation induction or augmentation of ovulation in WHO II infertile women, although these drugs are not approved for this indication and may have fetal toxicity.",
"   </p>",
"   <p>",
"    Based on the evidence reviewed above, aromatase inhibitors seem to be effective and have many advantages compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    citrate. These include monofollicular ovulation (especially in polycystic ovarian syndrome patients) and minimal to no need for ultrasound monitoring for endometrial thickness. Both of these advantages allow primary care providers or community-based gynecologists, without ready access to ultrasound monitoring, to participate in the management of PCOS and other anovulatory women. However, a large clinical trial directly comparing aromatase inhibitors to clomiphene is necessary to better define the risks and benefits of each method of ovulation induction.",
"   </p>",
"   <p>",
"    We would not use aromatase inhibitors alone for intrauterine insemination cycles (IUI) given that it is preferable to see two or three mature follicles developing in these cases, depending on the patient's age. In order to ensure multiple ovulation in IUI cycles, we would administer a low dose of FSH to the aromatase inhibitor, although FSH can be delayed (sequential protocol) until estradiol levels begin to rise and when the exogenous FSH administration would override negative feedback occurring centrally. This type of protocol does not accelerate follicle development and ovulation occurs normally around cycle day 14. There is adequate time for endometrial growth to occur normally and a small dose of gonadotropin is required, generally in the range of 50 to 75 IU daily.",
"   </p>",
"   <p>",
"    At this time, all aromatase inhibitors and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/26/36261?source=see_link\">",
"     letrozole",
"    </a>",
"    , in particular, should be used with caution, if at all, for ovulation induction in premenopausal women due to the potential for fetal toxicity and fetal malformations. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Safety'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/1\">",
"      Biljan, MM, et al. The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins. Fertil Steril 2005; 84:S95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/2\">",
"      Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006; 85:1761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/3\">",
"      Forman R, Gill S, Moretti M, et al. Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynaecol Can 2007; 29:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/4\">",
"      Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 1990; 33:2933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/5\">",
"      Buzdar A, Howell A. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Res 2001; 7:2620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/6\">",
"      Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002; 20:3317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/7\">",
"      Mauras N, Lima J, Patel D, et al. Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males. J Clin Endocrinol Metab 2003; 88:5951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/8\">",
"      Buzdar A, Jonat W, Howell A, et al. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol 1996; 14:2000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/9\">",
"      Marty, M, Gershanovich, M, Campos, B, Romien, G, et al. Aromatase inhibitors, a new potent, selective aromatase inhibitor superior to aminoglutethimide in postmenopausal women with advanced breast cancer previously treated with antioestrogens. Proc Am Soc Clin Oncol 1997; 16:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/10\">",
"      Hamilton A, Piccart M. The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer. Ann Oncol 1999; 10:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/11\">",
"      Goss PE. Risks versus benefits in the clinical application of aromatase inhibitors. Endocr Relat Cancer 1999; 6:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/12\">",
"      Kamat A, Hinshelwood MM, Murry BA, Mendelson CR. Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 2002; 13:122.",
"     </a>",
"    </li>",
"    <li>",
"     Naftolin F, MacLusky NJ. Aromatization hypothesis revisited. In: Sexual Differentiation: Basic and Clinical Aspects, Serio M (Ed), Raven Press, New York 1984. p.79.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/14\">",
"      Naftolin F, MacLusky NJ, Leranth CZ, et al. The cellular effects of estrogens on neuroendocrine tissues. J Steroid Biochem 1988; 30:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/15\">",
"      Naftolin F. Brain aromatization of androgens. J Reprod Med 1994; 39:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/16\">",
"      Roberts VJ, Barth S, el-Roeiy A, Yen SS. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J Clin Endocrinol Metab 1994; 79:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/17\">",
"      Yamoto M, Minami S, Nakano R. Immunohistochemical localization of inhibin subunits in polycystic ovary. J Clin Endocrinol Metab 1993; 77:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/18\">",
"      Anderson RA, Groome NP, Baird DT. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol (Oxf) 1998; 48:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/19\">",
"      Lockwood GM, Muttukrishna S, Groome NP, et al. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 1998; 83:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/20\">",
"      Weil SJ, Vendola K, Zhou J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998; 83:2479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/21\">",
"      Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84:2951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/22\">",
"      Vendola KA, Zhou J, Adesanya OO, et al. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101:2622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/23\">",
"      Vendola K, Zhou J, Wang J, et al. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 1999; 61:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/24\">",
"      Adashi EY. Intraovarian regulation: the proposed role of insulin-like growth factors. Ann N Y Acad Sci 1993; 687:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/25\">",
"      Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992; 13:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/26\">",
"      Yen SS, Laughlin GA, Morales AJ. Interface between extra- and intraovarian factors in polycystic ovarian syndrome. Ann N Y Acad Sci 1993; 687:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/27\">",
"      Agarwal SK, Judd HL, Magoffin DA. A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81:3686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/28\">",
"      Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod 1998; 4:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/29\">",
"      Hakim RB, Gray RH, Zacur H. Infertility and early pregnancy loss. Am J Obstet Gynecol 1995; 172:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/30\">",
"      Check JH, Dietterich C, Lurie D. The effect of consecutive cycles of clomiphene citrate therapy on endometrial thickness and echo pattern. Obstet Gynecol 1995; 86:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/31\">",
"      Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990; 5:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/32\">",
"      Ben-Ami M, Geslevich Y, Matilsky M, et al. Exogenous estrogen therapy concurrent with clomiphene citrate--lack of effect on serum sex hormone levels and endometrial thickness. Gynecol Obstet Invest 1994; 37:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/33\">",
"      Nelson LM, Hershlag A, Kurl RS, et al. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril 1990; 53:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/34\">",
"      Li TC, Warren MA, Murphy C, et al. A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women. Br J Obstet Gynaecol 1992; 99:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/35\">",
"      Sammour, A, Biljan, MM, Tan, SL, Tulandi, T. Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Fertil Steril 2001; 76:S110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/36\">",
"      Cort&iacute;nez A, De Carvalho I, Vantman D, et al. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 2005; 83:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/37\">",
"      Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004; 82:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/38\">",
"      Fatemi HM, Kolibianakis E, Tournaye H, et al. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online 2003; 7:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/39\">",
"      Al-Omari WR, Sulaiman WR, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2004; 85:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/40\">",
"      Tredway DR, Buraglio M, Hemsey G, Denton G. A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers. Fertil Steril 2004; 82:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/41\">",
"      Sipe CS, Davis WA, Maifeld M, Van Voorhis BJ. A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins. Fertil Steril 2006; 86:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/42\">",
"      Ligibel, JA, Winer, EP. Clinical Differences among the Aromatase Inhibitors. Clin Cancer Res 2003; 91:S473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/43\">",
"      de Ziegler D, Mattenberger C, Luyet C, et al. Clinical use of aromatase inhibitors (AI) in premenopausal women. J Steroid Biochem Mol Biol 2005; 95:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/44\">",
"      Mitwally, MFM, Casper, RF. Aromatase Inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 2000; 10:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/45\">",
"      Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/46\">",
"      Quintero RB, Urban R, Lathi RB, et al. A comparison of letrozole to gonadotropins for ovulation induction, in subjects who failed to conceive with clomiphene citrate. Fertil Steril 2007; 88:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/47\">",
"      Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2006; 91:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/48\">",
"      Al-Fadhli R, Sylvestre C, Buckett W, et al. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 2006; 85:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/49\">",
"      Sioufi A, Gauducheau N, Pineau V, et al. Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos 1997; 18:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/50\">",
"      Sioufi A, Sandrenan N, Godbillon J, et al. Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration. Biopharm Drug Dispos 1997; 18:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/51\">",
"      Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005; 83:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/52\">",
"      Biljan, MM, Tkalec, DD, Lachgar, H. A study comparing a single dose of 25mg of letrazole given on day 3 of menstrual cycle with a daily dose of 5mg of letrazole given between day 3 and day 7 of menstrual cycle in patients with unexplained infertility: Prospective randomized double blind trial. Fertil Steril 2004; 82:S81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/53\">",
"      Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002; 77:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/54\">",
"      Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003; 18:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/55\">",
"      Mitwally MF, Casper RF. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Investig 2004; 11:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/56\">",
"      Healey S, Tan SL, Tulandi T, Biljan MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2003; 80:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/57\">",
"      Schoolcraft, W, Surrey, E, Minjarez, D, Gardner, DK. Antagonist/letrozole protocol for patients failing microdose agonist flare stimulation. Fertil Steril 2002; 78:S234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/58\">",
"      Goswami SK, Das T, Chattopadhyay R, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 2004; 19:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/59\">",
"      Garcia-Velasco JA, Moreno L, Pacheco A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005; 84:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/60\">",
"      Tiboni GM. Aromatase inhibitors and teratogenesis. Fertil Steril 2004; 81:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/61\">",
"      Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/6/4201/abstract/62\">",
"      Reefhuis J, Honein MA, Schieve LA, et al. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. Hum Reprod 2011; 26:451.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7425 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-C38B34FA94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4201=[""].join("\n");
var outline_f4_6_4201=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY AND PHARMACOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Aromatase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Aromatase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Rationale for use in ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVIDENCE OF EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL USE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Controlled ovarian hyperstimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Poor responders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Women with breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PREGNANCY ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Safety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7425\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7425|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/14/5347\" title=\"figure 1\">",
"      Ovulation aromatase inhibitors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=related_link\">",
"      Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=related_link\">",
"      Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=related_link\">",
"      Metformin for treatment of the polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=related_link\">",
"      Ovulation induction with clomiphene citrate",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_6_4202="Tinea cruris";
var content_f4_6_4202=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56684%7EPC%2F63322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56684%7EPC%2F63322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea cruris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 302px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tinea cruris infection caused by T. rubrum involving the crural fold and medial aspect of the right thigh.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea cruris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous plaques with a slightly raised, well-demarcated border are present in the groin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4202=[""].join("\n");
var outline_f4_6_4202=null;
var title_f4_6_4203="LMA size";
var content_f4_6_4203=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F67558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F67558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Choosing an larnygeal mask airway (LMA)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        LMA size",
"       </td>",
"       <td class=\"subtitle1\">",
"        Patient weight (kgs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        up to 5 kgs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        5 to 10 kgs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        10 to 20 kgs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        20 to 30 kgs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        30 to 50 kgs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        50 to 70 kgs",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4203=[""].join("\n");
var outline_f4_6_4203=null;
var title_f4_6_4204="Salmonella serogroups";
var content_f4_6_4204=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Salmonella serogroups: Examples of important specific serotypes and their characteristic clinical infections",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Serogroup",
"       </td>",
"       <td class=\"subtitle1\">",
"        Example (serotype)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Characteristic syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A",
"       </td>",
"       <td>",
"        S. paratyphi A",
"       </td>",
"       <td>",
"        Enteric fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B",
"       </td>",
"       <td>",
"        S. paratyphi B",
"       </td>",
"       <td>",
"        Enteric fever or gastroenteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B",
"       </td>",
"       <td>",
"        S. typhimurium",
"       </td>",
"       <td>",
"        Gastroenteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B",
"       </td>",
"       <td>",
"        S. heidelberg",
"       </td>",
"       <td>",
"        Gastroenteritis, bacteremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        S. paratyphi C",
"       </td>",
"       <td>",
"        Enteric fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        S. choleraesuis",
"       </td>",
"       <td>",
"        Bacteremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        S. newport",
"       </td>",
"       <td>",
"        Gastroenteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D",
"       </td>",
"       <td>",
"        S. typhi",
"       </td>",
"       <td>",
"        Enteric fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D",
"       </td>",
"       <td>",
"        S. enteritidis",
"       </td>",
"       <td>",
"        Gastroenteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D",
"       </td>",
"       <td>",
"        S. dublin",
"       </td>",
"       <td>",
"        Bacteremia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * All listed serotypes are formally members of the species Salmonella enterica, subspecies enterica. There are many additional serotypes of Salmonellae that are named after geographical locales: S. javiana, S. tennessee, S. cubana, etc. Chronic biliary carriage occurs almost exclusively with S. typhi or S. paratyphi.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4204=[""].join("\n");
var outline_f4_6_4204=null;
var title_f4_6_4205="TBI HBI RAD NV trials";
var content_f4_6_4205=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Randomized trials for total-body or hemibody irradiation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Ref",
"      </td>",
"      <td class=\"subtitle1\">",
"       No. of patients",
"      </td>",
"      <td class=\"subtitle1\">",
"       Radiotherapy",
"      </td>",
"      <td class=\"subtitle1\">",
"       Antiemetic",
"      </td>",
"      <td class=\"subtitle1\">",
"       Complete response, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Results",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Tiley",
"       <sup>",
"        1",
"       </sup>",
"      </td>",
"      <td rowspan=\"2\">",
"       20",
"      </td>",
"      <td rowspan=\"2\">",
"       10.5 Gy (TBI, single fraction)",
"      </td>",
"      <td>",
"       OND (8 mg IV)",
"      </td>",
"      <td>",
"       90*",
"      </td>",
"      <td rowspan=\"2\">",
"       OND better than placebo",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Placebo",
"      </td>",
"      <td>",
"       50*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Spitzer",
"       <sup>",
"        2",
"       </sup>",
"      </td>",
"      <td rowspan=\"2\">",
"       20",
"      </td>",
"      <td rowspan=\"2\">",
"       TBI: 13.2 Gy in 11 fractions over 4 days",
"      </td>",
"      <td>",
"       OND (8 mg x 3/day PO)",
"      </td>",
"      <td>",
"       50",
"      </td>",
"      <td rowspan=\"2\">",
"       OND better than placebo",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Placebo",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Prentice",
"       <sup>",
"        3",
"       </sup>",
"      </td>",
"      <td rowspan=\"2\">",
"       30",
"      </td>",
"      <td rowspan=\"2\">",
"       7.5 Gy (TBI, single fraction)",
"      </td>",
"      <td>",
"       GRAN (3 mg IV)",
"      </td>",
"      <td>",
"       53",
"      </td>",
"      <td rowspan=\"2\">",
"       GRAN better than MTC + DEX + LOR",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       MCP (20 mg IV) + DEX (6 mg/m2 IV) + LOR (2 mg IV)",
"      </td>",
"      <td>",
"       13",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Huang",
"       <sup>",
"        4",
"       </sup>",
"      </td>",
"      <td rowspan=\"2\">",
"       116",
"      </td>",
"      <td rowspan=\"2\">",
"       7 to 7.7 Gy (TBI, single fraction)",
"      </td>",
"      <td>",
"       OND (8 mg) + DEX (10 mg)",
"      </td>",
"      <td>",
"       84",
"      </td>",
"      <td rowspan=\"2\">",
"       OND + DEX better than MCP + DEX",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       MCP (10 mg) + DEX (10 mg)",
"      </td>",
"      <td>",
"       20",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Sykes",
"       <sup>",
"        5",
"       </sup>",
"      </td>",
"      <td rowspan=\"2\">",
"       66",
"      </td>",
"      <td rowspan=\"2\">",
"       8 to 12.5 Gy (HBI, single fraction)",
"      </td>",
"      <td>",
"       OND (8 mg x 2 PO)",
"      </td>",
"      <td>",
"       94",
"      </td>",
"      <td rowspan=\"2\">",
"       OND better than CLP + DEX",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CLP (25 mg x 3 PO) + DEX (6 mg x 3 PO)",
"      </td>",
"      <td>",
"       34",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Spitzer",
"       <sup>",
"        6",
"       </sup>",
"      </td>",
"      <td rowspan=\"2\">",
"       34",
"      </td>",
"      <td rowspan=\"2\">",
"       TBI: 13.2 Gy in 11 fractions over 4 days",
"      </td>",
"      <td>",
"       OND (8 mg x 3/day PO)",
"      </td>",
"      <td>",
"       47",
"      </td>",
"      <td rowspan=\"2\">",
"       No difference",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       GRAN (2 mg x 1/day PO)",
"      </td>",
"      <td>",
"       61",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TBI: total body irradiation; HBI: hemibody irradiation; OND: ondansetron; GRAN: granisetron; MCP: metoclopramide; LOR: lorazepam; CLP: chlorpromazine; DEX: dexamethasone; PO: orally; IV: intravenously from (2009).",
"     <br>",
"      * All patients received intravenous dexamethasone (8 mg) and phenobarbitone (60 mg/m2).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     1. Tiley, C, et al. Leuk Lymphoma 1992; 7:317.",
"     <br>",
"      2. Spitzer, TR, et al. J Clin Oncol 1994; 12:2432.",
"      <br>",
"       3. Prentice, HG, et al. Bone Marrow Transplant 1995; 15:445.",
"       <br>",
"        4. Huang, X, et al. Zhonghua Zhong Liu Za Zhi 1995; 17:64.",
"        <br>",
"         5. Sykes, AJ, et al. Support Care Cancer 1997; 5:500.",
"         <br>",
"          6. Spitzer, TR, et al. Bone Marrow Transplant 2000; 26:203.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4205=[""].join("\n");
var outline_f4_6_4205=null;
var title_f4_6_4206="Contents: Cardiology calculators";
var content_f4_6_4206=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?5/3/5182\">",
"       Cardiovascular Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Cardiology calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Cardiology calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Clinical Criteria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/14/15599\">",
"           Calculator: 10 year risk of developing cardiovascular disease in men (Patient information)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15679\">",
"           Calculator: 10 year risk of developing cardiovascular disease in women (Patient information)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1633\">",
"           Calculator: Atrial fibrillation CHADS(2) score for stroke risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/28/44482\">",
"           Calculator: Framingham 10 year risk of general cardiovascular disease in men (2008 paper)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/63/10226\">",
"           Calculator: Framingham 10 year risk of general cardiovascular disease in women (2008 paper)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/53/28497\">",
"           Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for ST elevation acute myocardial infarction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/34/5665\">",
"           Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for unstable angina or non ST elevation myocardial infarction",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/62/25570\">",
"           Calculator: Cardiac Output",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/1/21521\">",
"           Calculator: Friedewald Equation for Low Density Lipoprotein (LDL-C)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/39/5746\">",
"           Calculator: Friedewald Equation for Low Density Lipoprotein (LDL-C, SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/26/29089\">",
"           Calculator: Lean body weight (adult female)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/21/29009\">",
"           Calculator: Lean body weight (adult male)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/59/28593\">",
"           Calculator: Pulmonary Vascular Resistance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/48/7937\">",
"           Calculator: QT Interval Correction (EKG)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/56/26497\">",
"           Calculator: Systemic Vascular Resistance",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3341A1FB16-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f4_6_4206=[""].join("\n");
var outline_f4_6_4206=null;
var title_f4_6_4207="Communication loop";
var content_f4_6_4207=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    The interactive communication loop in clinician-patient education",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 332px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Only by assessing recall and comprehension can the clinician ensure that a key concept has been understood and remembered. Not uncommonly, a patient responds to an initial assessment by demonstrating poor recall, lack of understanding, or health beliefs that may interfere with integration of the concept. The clinician should then repeat, clarify, or tailor subsequent information. To ensure recall and comprehension of this tailored explanation, the clinician should reassess the patient's recall and comprehension until a common understanding has been achieved. Recall and comprehension have been shown to be predictive of subsequent adherence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003: 163:83. Copyright &copy; 2003 American Medical Association. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_6_4207=[""].join("\n");
var outline_f4_6_4207=null;
